Showing 6481-6490 of 20414 results for "".
Hope or Hype -- The High Cost of Medical Advances
https://reachmd.com/programs/clinicians-roundtable/hope-or-hype-the-high-cost-of-medical-advances/1195/Dr. Michael Greenberg welcomes Dr. Richard Deyo, Professor of Medicine and Health Services at the University of Washington, Seattle, WA, as he discusses his book, Hope or Hype, and how physicians are seduced by the bottom line medical industry.Agitation in Alzheimer’s Dementia: From Expert Consensus to Clinical Practice
https://reachmd.com/programs/medical-industry-feature/agitation-alzheimers-dementia-expert-consensus-clinical-practice/36262/Nearly half of patients living with dementia due to Alzheimer’s disease will experience agitation during the course of illness.1 In June 2025, expert panel recommendations on identifying and managing agitation in Alzheimer’s dementia were published in Postgraduate Medicine. Learn more about these reUnderstanding Disparities in Migraine Diagnosis: Evidence from Real-World Data
https://reachmd.com/programs/neurofrontiers/disparities-migraine-diagnosis-real-world-data/49216/New research presented at the 2026 American Headache Society's Annual Scientific Meeting examines how demographic, social, and clinical factors may influence migraine diagnosis patterns among Arizona Medicaid recipients. Join Dr. Juliana VanderPluym, author and presenter of the study, as she discussPatient Voices in ATTR-CM: Driving Change in Diagnosis, Referral, and Support
https://reachmd.com/programs/on-the-frontlines-of-attr-cm/attr-cm-patient-voices/49033/What do patients with transthyretin amyloid cardiomyopathy (ATTR-CM) really experience during their diagnostic and care journeys? Find out as Dr. Quan Bui joins Ryan Quigley to share findings from in-depth patient interviews spotlighting delayed diagnoses, disparities in access, and the complexAssessing the Role of Metabolic Factors in Psoriasis Management
https://reachmd.com/programs/Audioabstracts/metabolic-factors-psoriasis-management/39678/Emerging research highlights a stronger-than-expected connection between body composition and psoriasis outcome, with a large real-world study examining how body mass index, basal metabolic rate, body surface area, and body weight impact both disease severity and biologic treatment response. Tune inTiming Meningococcal Vaccines in gMG: Challenges and Considerations
https://reachmd.com/programs/neurofrontiers/timing-meningococcal-vaccines-in-gmg-challenges-and-considerations/32861/Evolving vaccination guidelines and varying clinical opinions have created uncertainty around the timing of meningococcal immunization in patients with generalized myasthenia gravis (gMG). Tune in to hear Dr. Michael Weiss, who spoke with ReachMD at the AANEM 2025 Annual Meeting, discuss how he balaOCT Biomarkers as Predictors of Treatment Response in RVO-Related Macular Edema
https://reachmd.com/programs/eye-on-ocular-health/oct-biomarkers-as-predictors-of-treatment-response-in-rvo-related-macular-edema/37664/Retinal vein occlusion (RVO) is a leading cause of sudden vision loss, often complicated by macular edema that affects patient outcomes. While treatment options like anti-vascular endothelial growth factor agents and corticosteroid implants exist, predicting response remains a challenge. Hear Dr. MiVomiting Syndromes: A Closer Look at CVS and CHS in Adult Patients
https://reachmd.com/programs/gi-insights/vomiting-syndromes-a-closer-look-at-cvs-and-chs-in-adult-patients/36498/Cyclic vomiting syndrome (CVS) is often underdiagnosed in adults due to its episodic nature and symptom overlap with other conditions. Dr. David Levinthal joins Dr. Peter Buch to explore key diagnostic criteria, key differences between CVS and cannabinoid hyperemesis syndrome (CHS), and evidence-The Future of Precision Medicine in COPD Care: Biomarkers, AI, and Multimodal Data
https://reachmd.com/programs/frontlines-copd/the-future-of-precision-medicine-in-copd-care-biomarkers-ai-and-multimodal-data/36471/Precision medicine in chronic obstructive pulmonary disease (COPD) care is no longer a distant goal; it’s already taking shape through examples like using eosinophil counts to guide dupilumab therapy. But as Dr. Matthew Moll explains, this is just the beginning. Tune in to hear Dr. Moll talk about hOptimizing DMD Care Through Multidisciplinary Collaboration
https://reachmd.com/programs/neurofrontiers/optimizing-dmd-care-through-multidisciplinary-collaboration/35683/Due to its multisystemic nature, Duchenne muscular dystrophy (DMD) demands a collaborative, multidisciplinary approach. That’s why Dr. Kaitlin Batley joins us to share her insights on the essential role of integrated care teams—spanning cardiology, pulmonology, endocrinology, rehabilitation, palliat